Pfizer delays advertising Exubera

Share this article:
Pfizer will hold off on advertising Exubera to consumers for one year while it focuses on education. Pfizer CEO Hank McKinnell told attendees at a June Goldman Sachs Global Healthcare Conference that the company would focus on educating professionals on the inhaled insulin, doubling the length of its 6-month moratorium on DTC ads for new drugs. McKinnell's remarks were first reported in The Pink Sheet.
Share this article:
close

Next Article in News

Email Newsletters

More in News

Lilly takes on Amgen's Enbrel

Lilly takes on Amgen's Enbrel

Phase-III tests indicate Lilly's experimental treatment bests Amgen's for moderate-to-severe plaque psoriasis.

GSK Ellipta franchise expands

GSK Ellipta franchise expands

The FDA has approved Arnuity Ellipta for asthma.

Five things for pharma marketers to know: Thursday, August 21

Five things for pharma marketers to know: Thursday, ...

An Ebola survivor is set to leave Emory University Hospital, but the cause of the cure is uncertain, the FDA has approved a new type 1 diabetes test, and the ...